ジョージア州における血液がんの臨床試験
ジョージア州内の拠点で、血液がんに関する16件の研究が参加者を募集しています。
ジョージア州内の都市
公式研究テキスト（英語）
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Northwest Georgia Oncology Centers PC ( Site 0061), Marietta
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Northeast Georgia Medical Center Braselton, Braselton
- Atlanta VA Medical Center, Decatur
- Northeast Georgia Medical Center-Gainesville, Gainesville
- 他4件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
被験者募集中観察研究
0歳〜38歳 · 全性別 · 2026/10/01更新 · NCT06131801A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- Emory University Winship Cancer Institute, Atlanta
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT04634552Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 13, Augusta
被験者募集中第3相
18歳〜71歳 · 全性別 · 2026/09/23更新 · NCT07504458(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Winship Cancer Institute - Emory University, Atlanta
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04996875Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- City of Hope - Atlanta, Newnan
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/09/03更新 · NCT04588922Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Emory Healthcare - The Emory Clinic, Atlanta
- Georgia Cancer Center at Augusta University, Augusta
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT06001788A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- Emory Winship Cancer Institute, Atlanta
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/10更新 · NCT06823167PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- Northside Hospital, Atlanta
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT06665100A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Children's Healthcare of Atlanta, Atlanta
- Northside Hospital, Atlanta
- Georgia Cancer Center at Augusta University Health, Augusta
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Emory Winship Cancer Institute, Atlanta
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/24更新 · NCT04068597Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
- Caitlin Guzowski, Atlanta
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/16更新 · NCT05417971A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Emory Healthcare - The Emory Clinic, Atlanta
- Georgia Cancer Center at Augusta University, Augusta
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/13更新 · NCT05735184IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
- Emory University Hospital, Atlanta
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/06/03更新 · NCT06119685Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Healthcare of Atlanta, Emory University, Atlanta
被験者募集中第1相
1歳〜21歳 · 全性別 · 2024/12/06更新 · NCT05476770ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。